A detailed history of Vestcor Inc transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Vestcor Inc holds 84,677 shares of RDY stock, worth $1.21 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
84,677
Previous 84,677 -0.0%
Holding current value
$1.21 Million
Previous $6.45 Million 4.28%
% of portfolio
0.21%
Previous 0.22%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$64.27 - $69.9 $468,721 - $509,780
-7,293 Reduced 7.93%
84,677 $5.89 Million
Q3 2023

Nov 14, 2023

SELL
$61.9 - $72.77 $1.09 Million - $1.28 Million
-17,529 Reduced 16.01%
91,970 $6.15 Million
Q4 2022

Feb 15, 2023

SELL
$51.15 - $57.45 $697,737 - $783,675
-13,641 Reduced 11.08%
109,499 $5.67 Million
Q2 2022

Aug 15, 2022

SELL
$49.62 - $58.13 $754,968 - $884,447
-15,215 Reduced 11.0%
123,140 $6.82 Million
Q1 2022

May 16, 2022

BUY
$48.27 - $65.25 $60,240 - $81,432
1,248 Added 0.91%
138,355 $7.71 Million
Q4 2021

Feb 15, 2022

BUY
$59.5 - $67.25 $502,894 - $568,397
8,452 Added 6.57%
137,107 $8.97 Million
Q3 2021

Nov 15, 2021

BUY
$60.19 - $75.29 $848,257 - $1.06 Million
14,093 Added 12.3%
128,655 $8.38 Million
Q2 2021

Aug 16, 2021

BUY
$62.12 - $74.2 $991,310 - $1.18 Million
15,958 Added 16.18%
114,562 $8.42 Million
Q1 2021

May 17, 2021

SELL
$57.98 - $73.08 $347,880 - $438,480
-6,000 Reduced 5.74%
98,604 $6.05 Million
Q3 2020

Nov 16, 2020

BUY
$51.39 - $72.41 $197,286 - $277,981
3,839 Added 3.81%
104,604 $7.28 Million
Q2 2020

Aug 14, 2020

BUY
$39.55 - $54.65 $1.3 Million - $1.8 Million
32,900 Added 48.48%
100,765 $5.34 Million
Q4 2019

Feb 12, 2020

BUY
$36.66 - $41.78 $2.49 Million - $2.84 Million
67,865 New
67,865 $2.75 Million

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.37B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Vestcor Inc Portfolio

Follow Vestcor Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestcor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vestcor Inc with notifications on news.